not tagged
effector therapeutics
['lupus', 'effector ']
#acr2022 year in review. dr varga highlighted work by . in #lupus mice, adding cd38-i in a cd8+ t cell targeted manner improved effector function, reversed the defects and improved viral clearance. cd38 as a target could reduce infection in sle 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling ??